SLC6A4 and bowel dysfunction: As we did not assess other potential μ-opioid receptor agonist-induced adverse effects (e.g. respiratory depression, bowel dysfunction, etc.), we cannot speculate on the extent to which NET and SERT inhibition would influence the overall tolerability profile of the drug combinations studied.